244 related articles for article (PubMed ID: 28213747)
1. Bone morphogenetic protein-2 for the treatment of congenital pseudarthrosis of the tibia or persistent tibial nonunion in children and adolescents: A retrospective study with a minimum 2-year follow-up.
Hissnauer TN; Stiel N; Babin K; Rupprecht M; Hoffmann M; Rueger JM; Stuecker R; Spiro AS
J Mater Sci Mater Med; 2017 Apr; 28(4):60. PubMed ID: 28213747
[TBL] [Abstract][Full Text] [Related]
2. rhBMP-2 and Intramedullary Fixation in Congenital Pseudarthrosis of the Tibia.
Richards BS; Anderson TD
J Pediatr Orthop; 2018 Apr; 38(4):230-238. PubMed ID: 27261960
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in pediatric orthopaedics.
Stiel N; Hissnauer TN; Rupprecht M; Babin K; Schlickewei CW; Rueger JM; Stuecker R; Spiro AS
J Mater Sci Mater Med; 2016 Dec; 27(12):184. PubMed ID: 27787808
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: a case series.
Spiro AS; Babin K; Lipovac S; Stenger P; Mladenov K; Rupprecht M; Rueger JM; Stuecker R
J Bone Joint Surg Br; 2011 May; 93(5):695-9. PubMed ID: 21511938
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions.
Haubruck P; Tanner MC; Vlachopoulos W; Hagelskamp S; Miska M; Ober J; Fischer C; Schmidmaier G
Orthop Traumatol Surg Res; 2018 Dec; 104(8):1241-1248. PubMed ID: 30293748
[TBL] [Abstract][Full Text] [Related]
6. Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases.
Lee FY; Sinicropi SM; Lee FS; Vitale MG; Roye DP; Choi IH
J Bone Joint Surg Am; 2006 Mar; 88(3):627-33. PubMed ID: 16510831
[No Abstract] [Full Text] [Related]
7. Long-term outcome following additional rhBMP-7 application in revision surgery of aseptic humeral, femoral, and tibial shaft nonunion.
Hackl S; Hierholzer C; Friederichs J; Woltmann A; Bühren V; von Rüden C
BMC Musculoskelet Disord; 2017 Aug; 18(1):342. PubMed ID: 28784168
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
[TBL] [Abstract][Full Text] [Related]
9. Posterior Cervical Fusion With Recombinant Human Bone Morphogenetic Protein-2: Complications and Fusion Rate at Minimum 2-Year Follow-Up.
Dorward IG; Buchowski JM; Stoker GE; Zebala LP
Clin Spine Surg; 2016 Jul; 29(6):E276-81. PubMed ID: 27137152
[TBL] [Abstract][Full Text] [Related]
10. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
[TBL] [Abstract][Full Text] [Related]
11. Combination of intramedullary rod, wrapping bone grafting and Ilizarov's fixator for the treatment of Crawford type IV congenital pseudarthrosis of the tibia: mid-term follow up of 56 cases.
Zhu GH; Mei HB; He RG; Liu YX; Liu K; Tang J; Wu JY
BMC Musculoskelet Disord; 2016 Oct; 17(1):443. PubMed ID: 27770774
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.
Govender S; Csimma C; Genant HK; Valentin-Opran A; Amit Y; Arbel R; Aro H; Atar D; Bishay M; Börner MG; Chiron P; Choong P; Cinats J; Courtenay B; Feibel R; Geulette B; Gravel C; Haas N; Raschke M; Hammacher E; van der Velde D; Hardy P; Holt M; Josten C; Ketterl RL; Lindeque B; Lob G; Mathevon H; McCoy G; Marsh D; Miller R; Munting E; Oevre S; Nordsletten L; Patel A; Pohl A; Rennie W; Reynders P; Rommens PM; Rondia J; Rossouw WC; Daneel PJ; Ruff S; Rüter A; Santavirta S; Schildhauer TA; Gekle C; Schnettler R; Segal D; Seiler H; Snowdowne RB; Stapert J; Taglang G; Verdonk R; Vogels L; Weckbach A; Wentzensen A; Wisniewski T;
J Bone Joint Surg Am; 2002 Dec; 84(12):2123-34. PubMed ID: 12473698
[TBL] [Abstract][Full Text] [Related]
13. Pseudarthrosis in multilevel anterior cervical fusion with rhBMP-2 and allograft: analysis of one hundred twenty-seven cases with minimum two-year follow-up.
Shen HX; Buchowski JM; Yeom JS; Liu G; Lin N; Riew KD
Spine (Phila Pa 1976); 2010 Apr; 35(7):747-53. PubMed ID: 20228711
[TBL] [Abstract][Full Text] [Related]
14. The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series.
Richards BS; Oetgen ME; Johnston CE
J Bone Joint Surg Am; 2010 Jan; 92(1):177-85. PubMed ID: 20048110
[No Abstract] [Full Text] [Related]
15. Cost effectiveness of tibial nonunion treatment: A comparison between rhBMP-7 and autologous bone graft in two Italian centres.
Giorgio Calori M; Capanna R; Colombo M; De Biase P; O'Sullivan C; Cartareggia V; Conti C
Injury; 2013 Dec; 44(12):1871-9. PubMed ID: 24074829
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of recombinant human bone morphogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: a randomised controlled trial.
Das SP; Ganesh S; Pradhan S; Singh D; Mohanty RN
Int Orthop; 2014 Sep; 38(9):1987-92. PubMed ID: 24827969
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Controlled Trial Comparing rhBMP-2/Absorbable Collagen Sponge Versus Autograft for the Treatment of Tibia Fractures With Critical Size Defects.
Major Extremity Trauma Research Consortium (METRC)
J Orthop Trauma; 2019 Aug; 33(8):384-391. PubMed ID: 31022069
[TBL] [Abstract][Full Text] [Related]
18. Complications in Adult Patients with Down Syndrome Undergoing Cervical Spine Surgery Using Current Instrumentation Techniques and rhBMP-2: A Long-Term Follow-Up.
Siemionow K; Hansdorfer M; Janusz P; Mardjetko S
J Neurol Surg A Cent Eur Neurosurg; 2017 Mar; 78(2):113-123. PubMed ID: 27448197
[No Abstract] [Full Text] [Related]
19. Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: a comparison of dysphagia rates and outcomes in 150 patients.
Lu DC; Tumialán LM; Chou D
J Neurosurg Spine; 2013 Jan; 18(1):43-9. PubMed ID: 23157278
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pediatric spinal deformity with use of recombinant human bone morphogenetic protein-2.
Stiel N; Stuecker R; Kunkel P; Ridderbusch K; Hagemann C; Breyer S; Ebert N; Spiro AS
J Mater Sci Mater Med; 2018 Jun; 29(7):93. PubMed ID: 29938328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
